Concepedia

Publication | Open Access

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea

14

Citations

29

References

2022

Year

Abstract

Solriamfetol 300 mg/day significantly improved on-the-road driving performance in participants with EDS associated with OSA.

References

YearCitations

Page 1